Context: Human gonads arise as a pair of epithelial ridges on the surface of intermediate mesoderm (IM)-derived mesonephros. Toxic environmental factors and mutations in various genes are known to disturb normal gonadal development, but because of a lack of suitable in vitro models, detailed studies characterizing the molecular basis of the observed defects have not been performed.
R ecent studies have shown a clear increase in genital birth defects and in functional failures in male reproductive organs (1) . Sperm counts have decreased throughout Western countries, and the incidence of hypospadias and testicular cancers has increased (1, 2) . A number of investigators have associated these adverse trends with defects in gonadal development, possibly arising from environmental toxicants affecting normal development (1, 2) .
The development of mammalian gonads is initiated as thickening of the celomic epithelium overlying the intermediate mesoderm (IM)-derived mesonephros (3) . Gonads are at first bipotential and capable of differentiating in both male and female directions. Male-specific gonadal development is initiated soon after formation of the bipotential gonad via expression of Y-chromosomal sexdetermining region Y, whereas lack of such expression leads to development of the ovary (4) . Interestingly, despite several recent discoveries concerning gene expression patterns (5) and epigenetic (6, 7) and posttranscriptional gene regulatory mechanisms (8, 9) acting in testicular and ovarian development, little is known about the signaling cascades involved in the initiation of bipotential gonadal development. The results of several mutational studies in mice suggest that at least Gata4 (10), Emx2, Lhx9, Wt1 (2KTS isoform), and Nr5a1 (11) are crucial for early gonadal development. Ablation of any of these genes in mice results in failure to form the bipotential gonad (10, (12) (13) (14) or, in the case of Emx2, defects in the whole urogenital system (15) . The sequence in which these genes act upon gonadal development is not fully understood. However, according to a current model, Gata4 and Nr5a1 initiate differentiation of somatic gonadal cells, Lhx9 and Wt1 2KTS promote their proliferation to form the bipotential gonads, and Emx2 participates in epithelial-to-mesenchymal transition and ingression of the gonadal progenitors (16) .
In early embryonic development, bone morphogenetic proteins (BMPs), activins, and wingless-type mouse mammary tumor virus integration site (WNT) family members together specify the anterior and the posterior primitive streak (PS), the progenitors of the endoderm and mesoderm of the developing fetus, respectively (17, 18) . BMPs are also involved in specification of the distinct mesodermal subtypes during embryogenesis in vivo (19, 20) and in differentiation of mesodermal, trophectodermal, and extraembryonic lineages from human pluripotent stem cells (hPSCs) (21) (22) (23) (24) . Moreover, BMP signaling has been suggested to maintain survival of mesonephric mesenchyme preceding differentiation of somatic gonadal cells in mice (25) , and it is also associated with gonadal development in the chicken (26) . However, the role of BMP signaling has not been studied in connection with differentiation of human gonadal somatic cells, and no model to study human gonadal development currently exists. In the present work, we generated a protocol for studying early gonadal differentiation from hPSCs and investigated the roles of BMPs and activin A as well as canonical WNT/b-catenin signaling in the determination of bipotential gonadal cells.
Material and Methods

Cell culture and differentiation
The human embryonic stem cell (hESC) line H9 (46, XX) from the WiCell Research Institute (27) was maintained on Growth Factor Reduced Matrigel TM (Becton Dickinson) in Essential 8 TM Medium (Invitrogen). The cells were dissociated with 0.5 mM EDTA (Invitrogen) and split at a 1:6-1:10 ratio every 3 to 4 days, and the medium was changed every 1 to 2 days. For differentiation, subconfluent H9 cells were dissociated into single cells with 0.5 mM EDTA and seeded on human collagen type I-coated plates (Corning) at 1.5 3 10 5 cells per square centimeter. Growth factors and inhibitors [activin A at 1 to 100 ng/mL (Dr. Marko Hyvönen, Department of Biochemistry, University of Cambridge, UK), 3 to 5 mM CHIR-99021 (Selleckchem), 2 mM dorsomorphin (DM) (Selleckchem), BMP-7 at 10 to 100 ng/mL, BMP-2 and BMP-4 at 10 ng/mL (all from PeproTech), and 10 mM Y-27632 (Selleckchem)] were added to Dulbecco's modified Eagle medium/F12 + Glutamax (Invitrogen) supplemented with 13 B27 (Invitrogen). Cells were differentiated in the presence of indicated growth factors for 8 days, with a medium change every 1 to 2 days. All experiments were repeated at least three times, in duplicate wells.
Immunofluorescence
For immunofluorescence staining, cells were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 15 to 20 minutes at room temperature and washed with PBS. They were permeabilized with 0.5% Triton® X-100 (Fisher Scientific) in PBS for 15 
Real-time quantitative reverse transcription polymerase chain reaction
Total RNA was isolated with a NucleoSpin® RNA kit (Macherey Nagel). Residual genomic DNA was removed in a separate step by using ribonuclease-free deoxyribonuclease (Promega), after which the samples were purified by using an RNA clean-up kit (Macherey Nagel 
Flow cytometric analyses
Results
Sequential BMP inhibition and activation induces expression of bipotential gonadal genes
We modified the protocol described by Mae et al. (31) to maximally induce IM formation with the ability to further differentiate along the gonadal pathway. Figure 1 (a) shows a schematic representation of the protocol including markers used to identify differentiation stages. In the first phase, we tested 17 different culture conditions (protocols A through Q) as regards induction of bipotential gonadal markers by sequential variation of BMP signaling activation and inhibition, by using BMP-7 and DM, respectively [ Fig. 1(a) ]. The basal media contained the commonly used mesodermal inducers activin A and the canonical WNT pathway activator CHIR-99021. The results clearly indicated that if BMP was not inhibited in either of the first 2 days (protocols A through G), expression of the bipotential gonadal genes remained low, whereas lateral plate mesoderm/extraembryonic genes (HAND1, GATA6) were upregulated [ Fig. 1(b) ]. In contrast, BMP signaling inhibition during the first (protocols I through Q) or second day (protocol H) of differentiation induced expression of the bipotential gonadal genes EMX2, GATA4, WT1, and LHX9 at days 4 through 8 of differentiation. At the same time the expression of lateral plate mesoderm/extraembryonic genes (HAND1, GATA6) remained low. BMP inhibition also had a clear effect on neural differentiation. If DM was administered during the first 2 days, the neural marker genes PAX6 and SOX1 were moderately upregulated. Without DM, neural markers remained at low levels [ Fig. 1(b) ]. We selected two protocols, L and M [ Fig. 1(c) ], for more detailed studies, as they repeatedly produced clear induction of the IM markers LHX1, PAX2, and OSR1 at days 2 through 4 of culture and bipotential gonadal markers EMX2, GATA4, WT1, and LHX9 at day 8 [ Fig. 1(d) ]. Both protocols comprised sequential inhibition and activation of BMP signaling, the only difference being the duration of BMP stimulation (1 vs. 2 days) and subsequently the second BMP inhibition between days 2 and 4 of culture (2 days vs. 1) [ Fig. 1(a) and 1(c) ]. Interestingly, protocol M, with 2-day inhibition of BMP, induced more prominent expression of LHX9 and GATA4 but lower expression of EMX2 as compared with protocol L, with 1 day of inhibition [ Fig. 1(b) and 1(d) ]. Both protocols induced WT1 equally [ Fig. 1(b) and 1(d) ]. Moreover, coexpression of WT1 and GATA4 at day 8 of differentiation was observed in immunocytochemistry in cells differentiated by using protocol M [ Fig. 1(e) ], confirming their identity as bipotential gonadal precursors. However, because the expression of neural markers was also elevated [ Fig. 1(b) ], we next tested whether neural differentiation could be reduced and bipotential gonadal gene expression promoted by optimizing the concentrations of activin A or BMP-7 or by modifying the duration of WNT/b-catenin signaling activation. In addition, three different BMP ligands (BMP-2, -4, and -7) were tested to determine the most potent BMP to induce bipotential gonadal differentiation.
Duration of BMP stimulation determines the optimal BMP ligand and concentration in differentiation of bipotential gonadal cells
To evaluate the role of different BMPs in gonadal differentiation, we tested BMP-2, -4, and -7 at 10 ng/mL in protocols L and M. Independent of the length of stimulation, BMP-2 and BMP-7 induced comparable expression of bipotential gonadal markers and a moderate increase in PAX6 expression [ Fig. 2(a) and 2(b) ]. In contrast, in longer (2-day) stimulation in protocol L, BMP-4 induced only low expression of bipotential gonadal markers and high expression of lateral plate mesoderm/extraembryonic markers (HAND1, GATA6) [ Fig. 2(a) ]. One-day stimulation with BMP-4 in protocol M produced similar upregulation of gonadal markers as BMP-2 and -7 but also clearly more prominent HAND1 expression [ Fig. 2(b) ]. In both protocols, BMP-4 induced the lowest expression of neural marker genes [ Fig. 2(a) and 2(b) ].
BMP-7 was selected for further experiments, and the optimal concentration (10, 50, or 100 ng/mL) for differentiation of bipotential gonadal cells was determined next. With longer stimulation (protocol L), the highest expression of bipotential gonadal genes was achieved with the lowest BMP-7 concentration [ Fig. 3(a) , 10 ng/mL]. Higher concentrations of BMP-7 (50 or 100 ng/mL) induced high-level expression of GATA6 and HAND1 but also suppressed the expression of neural genes PAX6 and SOX1 [ Fig. 3(a) ].
With shorter BMP-7 stimulation (protocol M) the most optimal differentiation was achieved with 50 ng/mL, leading to strong induction of bipotential genes but low neural gene and only moderate GATA6 and HAND1 expression [ Fig. 3(a) ]. The differentiation efficiency was further evaluated by flow cytometric analysis [ Fig. 3(b)] . Surprisingly, even though BMP-7 at 50 ng/mL in protocol M produced the highest relative increase in GATA4 mRNA expression, the proportion of GATA4-positive cells at day 8 of differentiation was highest (41%), with BMP-7 at 10 ng/mL [ Fig. 3(b) ]. Protocol L, with longer BMP stimulation, showed a similar pattern of GATA4-positive cells (a lower concentration induced a higher proportion of positive cells), but the proportion of GATA4-positive cells did not exceed 12% at any concentration. The amount of PAX6-positive cells followed the mRNA levels in both protocols, with the highest proportion of PAX6-positive cells observed with BMP-7 at 10 ng/mL. These data imply that the optimal BMP concentration required for induction of bipotential gonadal differentiation in our protocols depends on the total exposure to BMP.
BMP and WNT/b catenin signaling act together in directing hESCs into bipotential gonadal-like cells
The optimal duration of WNT/b-catenin pathway activation in protocols L and M was determined by adding 5 mM (first day) and 3 mM (subsequent days) CHIR-99021 for 1 to 8 days. In protocol L, with 2 days of BMP administration, 2-day induction with CHIR-99021 produced the highest expression of WT1, GATA4, and LHX9 [ Fig.  4(a) ], whereas longer exposure reduced the expression of bipotential gonadal genes [ Fig. 4(a) ]. In protocol M, on the other hand, a minimum of 4 days of WNT/b-catenin pathway stimulation was needed to induce a prominent increase in the expression of bipotential gonadal genes [ Fig. 4(a)-4(c) ]. Similarly to protocol L, longer stimulation reduced the expression of gonadal markers, but it was Fig. 4(b) ]. These results were confirmed at the mRNA level [ Fig. 4(a) ] and by immunocytochemical staining [Fig. 4(c) , shown only for protocol M]. Taken together, the results demonstrate that WNT signaling is essential for differentiation of bipotential gonadal cells and that the optimal duration of WNT activation also depends on the duration of BMP stimulation.
A high activin A concentration is essential for differentiation of gonadal-like cells
In previously published IM protocols a wide range of activin A concentrations has been used (31, 32, 34-36) .
To optimize the concentration of activin A in our protocol during the first day of differentiation, we differentiated hESCs using protocol M with activin A at three concentrations (1, 10, and 100 ng/mL). Cells cultured with activin A at 1 ng/mL showed a remarkably distinct phenotype when compared with cells cultured with 10 or 100 ng/mL of activin A [ Fig. 5(a) ]. On the second day of differentiation, cells cultured with activin A at 1 ng/mL formed loosely attaching spheroids, which expanded poorly on the culture matrix [ Fig. 5(a) ]. In contrast, cells cultured with activin A at 10 or 100 ng/mL proliferated equally well on the dish [ Fig. 5(a) ]. Moderate (10 ng/mL) and high (100 ng/mL) concentrations of activin A induced a strong increase in the relative expression of the mesendoderm marker BRACHYURY at day 1 of differentiation, whereas the expression in cells treated with activin A at 1 ng/mL was only moderate [ Fig. 5(b) ]. Furthermore, 100 ng/mL of activin A induced a considerable increase in the relative expression of bipotential gonadal genes WT1, GATA4, and LHX9 by day 8 of differentiation, whereas their expression remained low in cells cultured with 1 ng/mL activin A [ Fig. 5(b) ]. Moreover, differentiation with activin A at 1 ng/mL induced high-level expression of neuroectodermal genes PAX6 and SOX1 [ Fig. 5(b) ]. Quantitative reverse transcription polymerase chain reaction results were confirmed by flow cytometric analysis: ;28% to 44% and 6% of the cells were GATA4-positive when cultured with activin A at 100 ng/mL or 1 ng/mL, respectively [ Fig. 5(c) ]. On the other hand, PAX6 was detected in only 6% of cells cultured with 100 ng/mL activin A compared with 84% of cells treated with 1 ng/mL. These data imply that a high concentration of activin A is needed for mesendodermal induction and for inducing expression of bipotential gonadal genes.
Discussion
In the current study we generated a stepwise directed protocol of differentiation of hESCs into bipotential gonadal cells via induction of IM and analyzed the combinatorial role of BMP, activin, and WNT signaling in gonadal development. Sequential inhibition and activation of BMP signaling during the first 4 days of differentiation were found to be crucial for the formation of IM able to develop into bipotential gonadal-like precursors. High-level activin A and WNT activation was sufficient for mesoderm induction, but without initial (day 1 or day 2) BMP inhibition none of the gonadal markers were upregulated, and the expression of extraembryonic and lateral mesoderm marker genes was concurrently induced. Although early inhibition of BMP activity was mandatory for gonadal differentiation, total lack of BMP activation (either endogenous or exogenous) resulted in low induction of gonadal markers, and instead, neural development was apparent. These results reflect the delicate balance in early fate determination, where activin and WNT promote mesodermal lineage commitment and BMP signaling further modulates it by blocking neural differentiation but also directing mesodermal differentiation toward IM and bipotential gonadal precursors.
The nodal/activin pathway is known to induce mesendoderm differentiation in hPSCs, and in most published protocols concerning differentiation of hPSCs in a mesendodermal direction activin A is used to inhibit neural fate and induce PS formation (37) . However, protocols showing IM differentiation without activin A have been described as well. In these protocols, high-level WNT activation (by CHIR-99021) alone has been sufficient to induce posterior PS, giving rise to IM (36, 38) . In our study concurrent administration of high concentrations of activin A and CHIR-99021 was likely to have been needed to overcome the suppressive effect of DM on activin activity and hence mesendodermal differentiation. DM provided at a moderate concentration (1-5 mM) inhibits the activin pathway in addition to the BMP pathway but does not silence it (39) . Notably, with .1-day stimulation, activin A and WNT drive endodermal differentiation (40) , further underlining the importance of correct sequential induction in early mesendodermal differentiation.
Although the initial BMP inhibition was sufficient for promoting gonadal differentiation, an additional short inhibition period further improved the expression of EMX2, which in murine studies has been shown to be necessary for the development of the whole adrenogenital tract (15) . Interestingly, two of our protocols (L and M), which differed only in the length of BMP signaling activation on the second and third day of differentiation, showed the most robust gonadal marker gene expression but produced slightly different expression patterns, especially of EMX2. The longer BMP activation in protocol L prominently increased EMX2 levels, and with shorter activation in protocol M, EMX2 expression remained moderate. BMP and WNT signaling have been shown to directly regulate Emx2 expression regionally during development of the dorsal telencephalon (41) . Consequently, we can speculate that the greater expression of EMX2 after differentiation in protocol L as compared with protocol M may be explained by the longer exposure to BMP, complemented with WNT signaling activation.
All BMPs act preferentially via type II and type I serine-threonine kinase receptor complexes and phosphorylate SMAD1/5/8 (42) but have distinct affinities to different type II BMP receptors (43) and may therefore induce distinct biological responses in any given assay. Indeed, in our study BMP-7 and BMP-2 showed equal gonadal induction in both more deeply analyzed protocols, whereas BMP-4 had time-dependent effects on differentiation. In previous studies BMP-4 and BMP-7 have been used in generation of IM and subsequently nephrogenic cell lineages (31, 34, 35) . However, it is important to acknowledge that distinct bioactivities of different BMP family members are possible and that even minor changes in protocols may result in large differences in differentiation outcomes.
During embryogenesis BMP concentration gradients specify the mediolateral axis and determine mesodermal subtypes in vivo (20) . Optimization of the BMP concentration for gonadal differentiation showed interesting differences depending on the length of stimulation. With longer BMP exposure the lowest concentration of BMP-7 was found to induce the greatest gonadal marker expression. However, a low concentration of BMP was not sufficient to block neural differentiation. On the contrary, high BMP induction for 2 days blocked neural but promoted lateral plate mesoderm/extraembryonic differentiation. These results highlight the importance of controlling both the concentration of BMP and the exposure time.
The effect of BMP-7 on gonadal development was connected not only to the duration and concentration of BMP itself but also to WNT signaling. Application of WNT activator for only a few days instead of a longer period has been shown to induce hESCs to generate anterior IM (44) , which contributes to the mesonephros (34) and gonads (3). In our hands, the optimal duration of WNT activation depended on the duration of BMP signaling, indicating again that the developmental outcome depends on balancing activities of different signaling pathways. Importantly, in both protocols we managed to suppress the expression of neural genes by activating WNT signaling for .1 day, suggesting that 24-hour transient activation of WNT signaling is insufficient for adequate mesodermal induction.
Conclusions
We have established a method for directed differentiation of bipotential gonadal cells by using hESCs. Because two of the tested protocols generated fairly similar expression of bipotential gonadal genes, we will use both of them in our future studies. We have also demonstrated that several signaling pathways cooperatively regulate differentiation of hESCs into bipotential gonadal cells and that both the extent (activin, BMP) and the length of stimulation (WNT, BMP) of the pathways balance the gonadal versus extraembryonic/trophectodermal or neural cell fate. When the length of BMP stimulation is shortened, WNT signaling stimulation must be extended and BMP concentration increased to enable gonadal differentiation. More studies are needed to unveil the pathways regulating differentiation of Sertoli and granulosa cells, which could be used as models for investigating the etiology of gonadal defects observed in Western countries.
